Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory biomarker profiling and chlormethine gel study in early-stage mycosis fungoides
NL-OMON52201Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mechlorethamine in mycosis fungoides (MF) and cutaneous T-cell lymphoma (CTCL) (2 cohorts), sponsored by Centre for Human Drug Research. Primary endpoints: Comparable biomarker measurements over time and within groups, Differences in biomarker measurements between groups and 1 more. Started Oct 2021; status: active, not recruiting.
02
Drugs
mechlorethamine
03
Conditions
mycosis fungoides (MF)cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NL-OMON52201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52201.